Published on
July 18, 2025
- 09:00 GMT
BIOPHARMA PEG Achieves FDA DMF Listings for Two PEG Derivatives
Two PEG-based intermediates from BIOPHARMA PEG now listed in FDA DMF, supporting regulatory needs for drug delivery and bioconjugation. WATERTOWN, MA, UNITED STATES, July 18, 2025 /EINPresswire.com/ -- BIOPHARMA PEG, a developer of functional …
Distribution channels:
Chemical Industry, Healthcare & Pharmaceuticals Industry
...
